Targeting murine small bowel and colon through selective superior mesenteric artery injection

Microsurgery

Volumn 30, Issue 6, 2010, Pages 487-493

  Porvasnik, Stacy L ^a   Mah, Cathryn ^a   Polyak, Steven ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHYLENE BLUE; MICROSPHERE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; FEASIBILITY STUDY; FLUORESCENCE MICROSCOPY; INTESTINE EPITHELIUM; MALE; MICROSURGERY; MOUSE; NONHUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; SMALL INTESTINE; SUPERIOR MESENTERIC ARTERY;

ANIMALS; FEASIBILITY STUDIES; INJECTIONS, INTRA-ARTERIAL; INTESTINAL MUCOSA; INTESTINES; MESENTERIC ARTERY, SUPERIOR; METHYLENE BLUE; MICE; MICE, INBRED BALB C; MICROSURGERY;

EID: 77957281858     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20767     Document Type: Article

References (20)

1. Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 2003;20:153-214. (Pubitemid 37237279)
2. Borchardt RT, Jeffrey A, Siahaan TJ, Gangwar S, Pauletti GM. Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies. Adv Drug Deliv Rev 1997;27:235-256.
3. Norris DA, Puri N, Sinko PJ. The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Deliv Rev 1998;34:135-154. (Pubitemid 28535109)
4. Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;353:362-368.
5. Fedorak RN, Gangl A, Elson CO, Rutgeerts P, Schreiber S, Wild G, Hanauer SB, Kilian A, Cohard M, LeBeaut A, Feagan B. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology 2000; 119:1473-1482. (Pubitemid 32198672)
6. Larson SD, Jackson LN, Chen LA, Rychahou PG, Evers BM. Effectiveness of siRNA uptake in target tissues by various delivery methods. Surgery 2007;142:262-269.
7. Shao G, Greathouse K, Huang Q, Wang CM, Sferra TJ. Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors. J Pediatr Gastroenterol Nutr 2006;43:168-179. (Pubitemid 44180500)
8. Sferra TJ, McNeely D, Johnson PR. Gene transfer to the intestinal tract: A new approach using selective injection of the superior mesenteric artery. Hum Gene Ther 1997;8:681-687.
9. Dregelid E, Haukaas S, Amundsen S, Eide GE, Soreide O, Lekven J, Svanes K. Microsphere method in measurement of blood flow to wall layers of small intestine. Am J Physiol 1986;250 (Part 1): G670-G678.
10. Cook MJ. Anatomy of the Laboratory Mouse. U.S.: Academic Press Inc., 1965.
11. Polyak S, Mah C, Porvasnik S, Herlihy JD, Campbell-Thompson M, Byrne BJ, Valentine JF. Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5. Dig Dis Sci 2008;53:1261-1270.
12. McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote effi- cient transduction independently of DNA synthesis. Gene Ther 2001; 8:1248-1254.
13. Uemura K, Tatewaki M, Harris MB, Ueno T, Mantyh CR, Pappas TN, Takahashi T. Magnitude of abdominal incision affects the duration of postoperative ileus in rats. Surg Endosc 2004;18:606-610.
14. Wehner S, Schwarz NT, Hundsdoerfer R, Hierholzer C, Tweardy DJ, Billiar TR, Bauer AJ, Kalff JC. Induction of IL-6 within the rodent intestinal muscularis after intestinal surgical stress. Surgery 2005;137:436-446. (Pubitemid 40432043)
15. Korolkiewicz RP, Ujda M, Dabkowski J, Ruczynski J, Rekowski P, Petrusewicz J. Differential salutary effects of nonselective and selective COX-2 inhibitors in postoperative ileus in rats. J Surg Res 2003;109:161-169.
16. Letendre L, Scott M, Dobson G, Hidalgo I, Aungst B. Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction. Pharm Res 2004;21:1457-1462.
17. Brown J, Haines S, Wilding IR. Colonic spread of three rectally administered mesalazine (Pentasa) dosage forms in healthy volunteers as assessed by gamma scintigraphy. Aliment Pharmacol Ther 1997;11:685-691. (Pubitemid 27376355)
18. Suda T, Liu D. Hydrodynamic gene delivery: Its principles and applications. Mol Ther 2007;15:2063-2069.
19. Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut 1997;41:763-770. (Pubitemid 28023178)
20. Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X. Rapid and highly ef- ficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther 2003;10:2105-2111.